Costco Wholesale's profit fell 15 percent, missing estimates, hurt by weaker gross margins in its fresh-food business and some non-foods merchandises.» Read More
CNBC's Morgan Brennan reports the pharmaceutical companies are developing oral therapies for the condition that could replace current treatments.
At least one analyst at Target pushed for an investigation into payment systems after government and industry reports.
NBC's Pete Williams reports the government has issued guidance for banks servicing legal marijuana businesses. CNBC's Jane Wells provides insight.
Feb 11- CVS Caremark Corp stuck to its 2014 sales forecast on Tuesday, a week after announcing it was giving up its $2 billion a year tobacco business, and said sales at its drugstores are off to a good start this year.
Feb 5- CVS Caremark Corp said on Wednesday that it would stop selling tobacco products at its 7,600 stores by October, becoming the first national drugstore chain in the United States to take cigarettes off the shelves.
Feb 5- CVS Caremark Corp said on Wednesday that it would stop selling tobacco products at its 7,600 stores by October, becoming the first national drugstore chain in the United States to take cigarettes off the shelf. "I think it will put pressure on other retailers who want to be in healthcare," said CVS Caremark Chief Medical Officer Dr.
Feb 5- CVS Caremark Corp said on Wednesday that it would stop selling tobacco products at its 7,600 stores by October, becoming the first U.S. drugstore chain to take cigarettes off the shelf. "I think it will put pressure on other retailers who want to be in healthcare," said CVS Caremark Chief Medical Officer Dr.
Global healthcare company Roche is confident of growth in emerging markets despite the economic slowdown.
Companies and industries that rely on low-income spenders could see a boost to the bottom line thanks to rising wages in many American states.
Michael Morrissey, Exelixis president & CEO, provides insight on clinical research of prostate cancer and its cancer drug Cometriq.
Biogen Idec CEO George Scangos discusses the busy year ahead for the company, including the EU launch of Tecfidera and when a dividend will be offered.
Eli Lilly Chairman & CEO John Lechleiter provides insight on its rights to an experimental migraine drug.
Eli Lilly Chairman & CEO John Lechleiter discusses its loss of major patents, its current pipeline and when its total costs will normalize.
CNBC's Morgan Brennan reports on the FDA's four expediting pipelines. The approval rates for the drugs in these pipelines tend to be higher than those plodding the more traditional course.
But the delay in packaging the liquid version has not affected supplies of regular Tamiflu, said the Roche unit that makes the medication.
Neurocrine Biosciences' president and CEO Kevin Gorman, Ph. D., provides insight on clinical trials for its tardive dyskinesia treatment.
CNBC's Josh Lipton reports on the HT Growth Fund, which plans to raise $100 million over the next two years for the legal marijuana market.
CNBC's Josh Lipton reports that legal recreational pot businesses could get investment from a fund.
Colorado has issued more than 300 licenses to marijuana dispensaries. Dan Danko, High Times Magazine senior editor, discusses how Colorado is properly regulating pot distribution and explains the rigorous application process to obtain a license.
Dec 20- Walgreen Co, the largest U.S. drugstore operator, reported higher quarterly sales on Friday, but an increase in promotions and a slowdown in the introduction of higher-profit generic drugs cut into its gross profit margin. Wasson said the business environment was challenging and said Walgreen would focus on containing costs to protect margins.